SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Interbody System
September 06, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 18, 2022 16:30 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance
August 02, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces Full Commercial Launch of Meridian™ Anterior Lumbar Interbody System Featuring Reef ™ A Interbody
August 01, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference
July 26, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine to Report Second Quarter 2022 Financial Results on August 2, 2022
July 20, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit Facility
July 19, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces Full Commercial Launch of WaveForm® C 3D-printed Interbody System
June 21, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Announces Full Commercial Launch of the WaveForm™ TO (TLIF Oblique) 3D-Printed Interbody System
June 08, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Reports 21 Percent Revenue Growth for First Quarter 2022 and Increases Full Year 2022 Revenue Guidance
May 03, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...